Sabra Health Care REIT Inc. (NASDAQ:SBRA) shares traded lower over the last trading session, losing -2.55% on 10/13/20. The shares fell to a low of $14.11 before closing at $14.34. Intraday shares traded counted 0.99 million, which was 22.28% higher than its 30-day average trading volume of 1.28M. SBRA’s previous close was $14.72 while the outstanding shares total 205.59M. The firm has a beta of 1.39, a 12-month trailing P/E ratio of 22.55, and a growth ratio of 3.76. The stock’s Relative Strength Index (RSI) is 45.85, with weekly volatility at 3.34% and ATR at 0.60. The SBRA stock’s 52-week price range has touched low of $5.55 and a $24.95 high.
Investors have identified the REIT – Healthcare Facilities company Sabra Health Care REIT Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $3.02 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Sabra Health Care REIT Inc. (SBRA) Fundamentals that are to be considered.
SBRA were able to record 55.79 million as free cash flow during the third quarter of the year, this saw their quarterly net cash flow reduce by -12.34 million. In cash movements, the company had a total of 168.6 million as operating cash flow.
Potential earnings growth for Sabra Health Care REIT Inc. (SBRA)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the third quarter of the year, Sabra Health Care REIT Inc. recorded a total of 153.92 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with -42.52% coming in sequential stages and their sales for the third quarter increasing by 2.97%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 86.31 million trying to sell their products during the last quarter, with the result yielding a gross income of 67.61 million. This allows shareholders to hold on to 205.59M with the revenue now reading 0.14 cents per share. This is a figure that is close to analyst’s prediction for their fourth quarter (0.40 cents a share).
Having a look at the company’s valuation, the company is expected to record 1.86 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on SBRA sounds very interesting.
Is the stock of SBRA attractive?
In related news, Director, FOSTER MICHAEL J bought 9,675 shares of the company’s stock in a transaction that recorded on Mar 16. The purchase was performed at an average price of 7.71, for a total value of 74,629. As the purchase deal closes, the Director, FOSTER MICHAEL J now bought 3,200 shares of the company’s stock, valued at 24,800. Also, Director, Ettl Robert A. sold 10,545 shares of the company’s stock in a deal that was recorded on Mar 06. The shares were cost at an average price of 18.39 per share, with a total market value of 193,918. Following this completion of disposal, the Chairman, CEO and President, MATROS RICHARD K now holds 113,000 shares of the company’s stock, valued at 2,717,277. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.80%.
4 out of 15 analysts covering the stock have rated it a Buy, while 9 have maintained a Hold recommendation on Sabra Health Care REIT Inc.. 1 analysts has assigned a Sell rating on the SBRA stock. The 12-month mean consensus price target for the company’s shares has been set at $15.44.